Efficacy and Safety of Escitalopram in Patients With Generalized Anxiety Disorder; Open-Label, One Arm Postmarketing Study in Russia.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2012
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 01 Apr 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 01 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2010 Planned end date changed from 1 Jan 2010 to 1 Feb 2010 as reported by ClinicalTrials.gov.